Piper Sandler Maintains Overweight on ViewRay, Lowers Price Target to $6
Piper Sandler analyst Jason Bednar maintains ViewRay (NASDAQ:VRAY) with a Overweight and lowers the price target from $7 to $6.
ViewRay: Q2 Earnings Insights
ViewRay (NASDAQ:VRAY) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
ViewRay reported in-line EPS of $-0.15 versus an estimate of $-0.15.
Earnings Scheduled For August 2, 2022
Companies Reporting Before The Bell
• Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.
Earnings Preview For ViewRay
ViewRay (NASDAQ:VRAY) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement.
Analysts estimate that ViewRay will report an earnings per share (EPS) of $-0.15.
BTIG Maintains Buy on ViewRay, Lowers Price Target to $8
BTIG analyst Marie Thibault maintains ViewRay (NASDAQ:VRAY) with a Buy and lowers the price target from $9 to $8.
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
bluebird bio (NASDAQ:BLUE) shares rose 53.4% to $6.12 during Friday's after-market session. Trading volume for this security closed at 5.0 million, accounting for 206.3% of its average full-day volume over the last 100 days. The company's market cap stands at $437.2 million.
VA Ann Arbor Healthcare System Selects ViewRay To Expand Advanced Radiation Therapy Services
ViewRay, Inc. (NASDAQ:VRAY) announced today that the VA Ann Arbor Healthcare System (VAAAHS) has selected a MRIdian MRI-guided radiation therapy system to expand radiation therapy services at the Lieutenant Colonel
Insider Buying Remains Elevated For A Second Week $SBUX $UBER $RILY
In an unusually volatile week, we saw significant market weakness earlier in the week probably driven by forced selling and a relief rally in the end. Insiders once again stepped up their purchases to take advantage of prices, which in some cases are down anywhere from 50% to 90% from their peaks.
90 Biggest Movers From Yesterday
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.
58 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.